Abstract
Edward Mills, a professor of health sciences at McMaster University in Canada, offered significant new evidence that
Jul 7, 2022 · Edward Mills 5
Please help us continue this coverage by subscribing
The relative risk of hospitalization or prolonged observation in the emergency department owing to Covid-19 (the primary outcome) in the ivermectin group as compared with the placebo group was 0
“There was no indication that ivermectin is clinically useful,” said Edward Mills, one of the study’s lead researchers and a professor of health sciences at Canada’s McMaster University in Hamilton, Ontario
During the study, subjects who were diagnosed with COVID-19 underwent a specific medical visit to assess COVID-19 clinical manifestations and severity
Data Sources Original meta-analysis as well as a manual review of all references in a dedicated ivermectin trial database (c19ivermectin) from January 1, 2019, to November 6, 2021
Researchers testing repurposed drugs against Covid-19 found that ivermectin didn’t reduce hospital admissions, in the largest trial yet of the effect of the Meninger: No need to drive to New Hampshire
All the other three drugs mentioned earlier have passed this test; ivermectin has not